Table 1.
Desired and acceptable biomarker attributes
| Attribute | Desired | Acceptable |
|---|---|---|
| Specific for paracetamol overdose | Exclusively elevated by paracetamol-induced injury | Liver injury |
| Sensitivity for ruling out injury | ROC-AUC 1 | AUC ≥ 0.90 |
| Rapidly assayed | At point of care | <60 min turn around time |
| Feasibility of assay | Feasible in settings where resources are sparse (developing countries) | Feasible in standard clinical laboratories (developed countries) |
| Invasiveness / sample preparation time | Whole blood | Plasma/serum |
| Conserved (translational) across in vitro models, in vivo models and humans | Fully conserved between in vitro models, in vivo models and humans | Conserved between rodent models and humans |
| Time after overdose at which it is able to predict the onset of liver injury | 4 h | 8 h |
| Signal to noise | Single measure required to differentiate between healthy reference value and disease | Requires measurement at two time points |
| Quantitative relationship with disease severity | Quantitative | Qualitative |
| Distinguish benign and clinical relevant increase in ALT | Predicts liver failure | Predicts ALT rise |
| Mediator of liver injury | Has existing therapeutic intervention | Potential drug target |